New hope for rare disease patients with Non-Healing wounds
NCT ID NCT04914247
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This program offers selexipag (Uptravi) to a single patient with Buerger's disease who has a wound that won't heal. The goal is to see if the drug can help control the disease and improve wound healing. This is not a cure, and the patient may need ongoing treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HEALING WOUND are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists dig into why diabetic wounds stay open
- Antibiotic shots around wounds could speed healing in new trial
- New patch helps heal stubborn wounds at home
- New ultrasound could revolutionize chronic wound monitoring
- Tiny study sucks up wound goo to unlock healing secrets
- 5,000 patients to help reveal which wound dressings heal best